Skip to main content
SpringerLink
Log in

Risks, Benefits and Management of Pharmacologic Therapy in Patients with Implantable Cardioverter-Defibrillators

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Horowitz LN, Zipes DP, Bigger JT, Jr, Campbell RW, Morganroth J, Podrid PJ, Rosen MR, Woosley RL. Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia-A status report, 1987. Am J Cardiol 1987;59(11):54E-56E.

    Google Scholar 

  2. Josephson ME. Antiarrhythmic agents and the danger of proarhythmic events. Ann Intern Med 1989;111(2):101-103.

    Google Scholar 

  3. Dhein S, Muller A, Gerwin R, Klaus W. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 1993;87:617-630.

    Google Scholar 

  4. Calkins H, Leon AR, Deam AG, Kalbfleisch SJ, Langberg JJ, Morady F. Catheter ablation of atrial flutter using radiofrequency energy. Am J Cardiol 1994;73(5):353-356.

    Google Scholar 

  5. Cosio FG, Arribas F, Lopez-Gil M, Pālācios J. Radiofrequency catheter ablation of atrial flutter circuits. Arch Mal Coeur Vaiss 1996; 89 Spec No 1:75-81.

    Google Scholar 

  6. Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998;98:308-314.

    Google Scholar 

  7. Stevenson WG, Friedman PL, Sweeney MO. Catheter ablation as an adjunct to ICD therapy (editorial comment). Circulation 1997;96(5):1378-1380.

    Google Scholar 

  8. Feld GK. Radiofrequency catheter ablation versus modification of the AV node for control of rapid ventricular response in atrial fibrillation. J Cardiovasc Electrophysiol 1995; 6(3)217-228.

    Google Scholar 

  9. Kalman JM, Scheinman MM. Radiofrequency catheter ablation for atrial fibrillation. Cardiol Clin 1997;15(4): 721-737.

    Google Scholar 

  10. Haissaguerre M, Gencel L, Fischer B, LeMétayer P, Poquet F, Marcus FI, Clémenty J. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994;5(12): 1045-1052.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Electrophysiology Service, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA

    Michael R. Lauer & Ruey J. Sung

Authors
  1. Michael R. Lauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruey J. Sung
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauer, M.R., Sung, R.J. Risks, Benefits and Management of Pharmacologic Therapy in Patients with Implantable Cardioverter-Defibrillators. Card Electrophysiol Rev 2, 287–290 (1998). https://doi.org/10.1023/A:1009990308599

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009990308599

Keywords

Search

Navigation